Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.
Thümmler L, Konik M, Lindemann M, Fisenkci N, Koldehoff M, Gäckler A, Horn PA, Theodoropoulos F, Taube C, Zettler M, Anastasiou OE, Braß P, Jansen S, Witzke O, Rohn H, Krawczyk A. Thümmler L, et al. Among authors: horn pa. Front Immunol. 2022 Oct 13;13:980698. doi: 10.3389/fimmu.2022.980698. eCollection 2022. Front Immunol. 2022. PMID: 36311723 Free PMC article.
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H, Schramm S, Pansikaki K, Jansen S, Hendriks C, Platte M, Konik MJ, Dolff S, Wilde B, Kordelas L, Trilling M, Krawczyk A, Horn PA, Witzke O, Rebmann V. Rohn H, et al. Among authors: horn pa. Hum Immunol. 2023 Aug;84(8):393-400. doi: 10.1016/j.humimm.2023.03.002. Epub 2023 Mar 14. Hum Immunol. 2023. PMID: 36925435 Free PMC article.
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.
Offergeld R, Preußel K, Zeiler T, Aurich K, Baumann-Baretti BI, Ciesek S, Corman VM, Dienst V, Drosten C, Görg S, Greinacher A, Grossegesse M, Haller S, Heuft HG, Hofmann N, Horn PA, Houareau C, Gülec I, Jiménez Klingberg CL, Juhl D, Lindemann M, Martin S, Neuhauser HK, Nitsche A, Ohme J, Peine S, Sachs UJ, Schaade L, Schäfer R, Scheiblauer H, Schlaud M, Schmidt M, Umhau M, Vollmer T, Wagner FF, Wieler LH, Wilking H, Ziemann M, Zimmermann M, der Heiden MA. Offergeld R, et al. Among authors: horn pa. Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551. Pathogens. 2023. PMID: 37111436 Free PMC article.
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Hoffmann O, Wormland S, Bittner AK, Hölzenbein J, Schwich E, Schramm S, Rohn H, Horn PA, Kimmig R, Kasimir-Bauer S, Rebmann V. Hoffmann O, et al. Among authors: horn pa. Front Immunol. 2023 May 22;14:1188030. doi: 10.3389/fimmu.2023.1188030. eCollection 2023. Front Immunol. 2023. PMID: 37283737 Free PMC article.
HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells.
Kansy BA, Wehrs TP, Bruderek K, Si Y, Ludwig S, Droege F, Hasskamp P, Henkel U, Dominas N, Hoffmann TK, Horn PA, Schuler M, Gauler TC, Lindemann M, Lang S, Bankfalvi A, Brandau S. Kansy BA, et al. Among authors: horn pa. Cancer Immunol Immunother. 2023 Dec;72(12):4367-4383. doi: 10.1007/s00262-023-03571-8. Epub 2023 Nov 29. Cancer Immunol Immunother. 2023. PMID: 38019346 Free PMC article.
245 results